Transplantation of Induced Pluripotent Stem Cell-Derived Airway Epithelia with a Collagen Scaffold into the Nasal Cavity
Tissue Engineering Part C: Methods · 2023
DOI: 10.1089/ten.tec.2023.0074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Tissue Engineering Part C: Methods, 2023. Verfasst von Yuji Kitada und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Graduate School of medicine, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.
Abstract (Originalsprache)
The nasal cavity is covered with respiratory epithelia, including ciliated cells that eliminate foreign substances trapped in the mucus. In hereditary diseases such as primary ciliary dyskinesia and cystic fibrosis, respiratory epithelial functions are irreversibly impaired; however, no radical treatment has been established yet. Thus, we considered that the transplantation of normal airway epithelia (AE) into the nasal epithelia is one of the strategies that could lead to radical treatment in the future. In our previous study, human induced pluripotent stem cell-derived AE (hiPSC-AE) on the vitrigel membrane were transplanted into the scraped area of the nasal septal mucosa of nude rats. Although human-derived ciliated cells, club cells, and basal cells were observed, they were located in the cysts within the submucosal granulation tissue but not in the nasal mucosal epithelia and the transplanted cells may not contribute to the function of the nasal mucosa with this condition. Therefore, to achieve more functional transplantation, we prepared the graft differently in this study by wrapping the collagen sponge in hiPSC-AE on the vitrigel membrane. As a result, we found the transplanted cells surviving in the nasal mucosal epithelia. These results suggest that hiPSC-AE transplanted into the nasal cavity could be viable in the nasal mucosa. In addition, our method leads to the establishment of nasal mucosa-humanized rats that are used for the development of the drugs and therapeutic methods for hereditary diseases of nasal respiratory epithelia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Graduate School of medicine, Kyoto University, Kyoto, Japan.
- Department of Otolaryngology, Kobe City Medical Center General Hospital, Kobe City, Japan.
ORCID-Profile: Hiroe Ohnishi, Norio Yamamoto, Fumihiko Kuwata, Keisuke Mizuno
Zitieren
APA
Kitada, Y., Ohnishi, H., Yamamoto, N., Kuwata, F., Kitano, M., Mizuno, K., & Omori, K. (2023). Transplantation of Induced Pluripotent Stem Cell-Derived Airway Epithelia with a Collagen Scaffold into the Nasal Cavity. Tissue Engineering Part C: Methods. https://doi.org/10.1089/ten.tec.2023.0074
Vancouver
Kitada Y, Ohnishi H, Yamamoto N, Kuwata F, Kitano M, Mizuno K, et al. Transplantation of Induced Pluripotent Stem Cell-Derived Airway Epithelia with a Collagen Scaffold into the Nasal Cavity. Tissue Engineering Part C: Methods. 2023. doi:10.1089/ten.tec.2023.0074
BibTeX
@article{Kitada2023,
author = {Kitada, Yuji and Ohnishi, Hiroe and Yamamoto, Norio and Kuwata, Fumihiko and Kitano, Masayuki and Mizuno, Keisuke and Omori, Koichi},
title = {Transplantation of Induced Pluripotent Stem Cell-Derived Airway Epithelia with a Collagen Scaffold into the Nasal Cavity},
journal = {Tissue Engineering Part C: Methods},
year = {2023},
doi = {10.1089/ten.tec.2023.0074}
}
EUVIMED